Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer

    Metastasis occurs frequently after resection of pancreatic cancer (PaC). In this study, we hypothesized that multi-parametric analysis of pre-metastatic liver biopsies would classify patients according to thei...

    Linda Bojmar, Constantinos P. Zambirinis, Jonathan M. Hernandez in Nature Medicine (2024)

  2. Article

    Open Access

    Targeting pancreatic cancer metabolic dependencies through glutamine antagonism

    Pancreatic ductal adenocarcinoma (PDAC) cells use glutamine (Gln) to support proliferation and redox balance. Early attempts to inhibit Gln metabolism using glutaminase inhibitors resulted in rapid metabolic r...

    Joel Encarnación-Rosado, Albert S. W. Sohn, Douglas E. Biancur in Nature Cancer (2024)

  3. Article

    Open Access

    Author Correction: Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment

    Gregor Werba, Daniel Weissinger, Emily A. Kawaler, Ende Zhao in Nature Communications (2023)

  4. Article

    Open Access

    Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment

    The tumor microenvironment (TME) in pancreatic ductal adenocarcinoma (PDAC) is a complex ecosystem that drives tumor progression; however, in-depth single cell characterization of the PDAC TME and its role in ...

    Gregor Werba, Daniel Weissinger, Emily A. Kawaler, Ende Zhao in Nature Communications (2023)

  5. Article

    Open Access

    Impact of changing guidelines on genetic testing and surveillance recommendations in a contemporary cohort of breast cancer survivors with family history of pancreatic cancer

    Changing practice guidelines and recommendations have important implications for cancer survivors. This study investigated genetic testing patterns and outcomes and reported family history of pancreatic cancer...

    Annie Wang, Jessica N. Everett, Jennifer Chun, Cindy Cen in Scientific Reports (2021)

  6. No Access

    Article

    A novel target for combination immunotherapy in pancreatic cancer: IL-1β mediates immunosuppression in the tumour microenvironment

    Immune checkpoint blockade (ICB) has demonstrated efficacy in multiple cancers, offering the potential of long-term disease control not achievable with cytotoxic or targeted therapies. However, the field has n...

    Rafael Winograd, Diane M. Simeone, Dafna Bar-Sagi in British Journal of Cancer (2021)

  7. Article

    Open Access

    Dominant role of CDKN2B/p15INK4B of 9p21.3 tumor suppressor hub in inhibition of cell-cycle and glycolysis

    Human chromosome 9p21.3 is susceptible to inactivation in cell immortalization and diseases, such as cancer, coronary artery disease and type-2 diabetes. Although this locus encodes three cyclin-dependent kina...

    Yong **a, Yan Liu, Chao Yang, Diane M. Simeone, Tung-Tien Sun in Nature Communications (2021)

  8. Article

    Author Correction: Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas

    A Correction to this paper has been published: https://doi.org/10.1038/s41587-019-0392-8.

    Reuben Moncada, Dalia Barkley, Florian Wagner, Marta Chiodin in Nature Biotechnology (2020)

  9. No Access

    Article

    Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas

    Single-cell RNA sequencing (scRNA-seq) enables the systematic identification of cell populations in a tissue, but characterizing their spatial organization remains challenging. We combine a microarray-based sp...

    Reuben Moncada, Dalia Barkley, Florian Wagner, Marta Chiodin in Nature Biotechnology (2020)

  10. Article

    Open Access

    New Labyrinth Microfluidic Device Detects Circulating Tumor Cells Expressing Cancer Stem Cell Marker and Circulating Tumor Microemboli in Hepatocellular Carcinoma

    Hepatocellular Carcinoma (HCC) is one of the most lethal cancers with a high mortality and recurrence rate. Circulating tumor cell (CTC) detection offers various opportunities to advance early detection and mo...

    Shanshan Wan, Tae Hyun Kim, Kaylee J. Smith, Ryan Delaney, G-Su Park in Scientific Reports (2019)

  11. No Access

    Article

    ATDC mediates a TP63-regulated basal cancer invasive program

    Basal subtype cancers are deadly malignancies but the molecular events driving tumor lethality are not completely understood. Ataxia-telangiectasia group D complementing gene (ATDC, also known as TRIM29), is high...

    Phillip L. Palmbos, Yin Wang, Armand Bankhead III, Alan J. Kelleher in Oncogene (2019)

  12. No Access

    Protocol

    Pancreatic Microtumors: A Novel 3D Ex Vivo Testing Platform

    The tumor microenvironment plays a vital role in therapeutic resistance in pancreatic adenocarcinoma. We have created a 3D model to study the tumor microenvironment ex vivo that integrates tumor cells with tum...

    Mackenzie Lee Goodwin, Sumi Kanthraj Urs, Diane M. Simeone in Pancreatic Cancer (2019)

  13. No Access

    Reference Work Entry In depth

    Pancreatic Cancer Stem Cells

    Cancer stem cells (CSCs) are a distinct subpopulation of cells within a tumor that are capable of self-renewal and producing differentiated progeny. These cells appear to be more resilient to treatment than bu...

    Mackenzie Goodwin, Ethan V. Abel, Vinee Purohit, Diane M. Simeone in Pancreatic Cancer (2018)

  14. No Access

    Reference Work Entry In depth

    Pancreatic Cancer Stem Cells

    Diane M. Simeone in Encyclopedia of Cancer (2017)

  15. No Access

    Article

    A phase I trial of cabozantinib and gemcitabine in advanced pancreatic cancer

    Background Cabozantinib and gemcitabine improve tumor control in pancreatic ductal adenocarcinoma (PDAC) in preclinical models through c-Met inhibition. We sought to determine the maximum...

    David B. Zhen, Kent A. Griffith, Joshua M. Ruch in Investigational New Drugs (2016)

  16. No Access

    Living Reference Work Entry In depth

    Pancreatic Cancer Stem Cells

    Cancer stem cells (CSCs) are a distinct subpopulation of cells within a tumor that are capable of self-renewal and producing differentiated progeny. These cells appear to be more resilient to treatment than bu...

    Mackenzie Goodwin, Ethan V. Abel, Vinee Purohit, Diane M. Simeone in Pancreatic Cancer

  17. No Access

    Living Reference Work Entry In depth

    Pancreatic Cancer Stem Cells

    Diane M. Simeone in Encyclopedia of Cancer

  18. Article

    Erratum: Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets

    Nature Nanotechnology 8, 735–741 (2013); published online 29 September 2013; corrected after print 1 October 2013. In the version of this Letter originally published, in Fig. 1b one of the PEG chains was mispl...

    Hyeun Joong Yoon, Tae Hyun Kim, Zhuo Zhang, Ebrahim Azizi in Nature Nanotechnology (2013)

  19. No Access

    Article

    Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets

    The spread of cancer throughout the body is driven by circulating tumour cells (CTCs)1. These cells detach from the primary tumour and move from the bloodstream to a new site of subsequent tumour growth. They als...

    Hyeun Joong Yoon, Tae Hyun Kim, Zhuo Zhang, Ebrahim Azizi in Nature Nanotechnology (2013)

  20. No Access

    Article

    Breast Cancer Metastases to the Pancreas

    The pancreas can serve as the destination for metastatic spread of malignancies from multiple organ sites. Breast cancer metastases to the pancreas are part of this spectrum and surgeons evaluate such patients...

    Filip Bednar, James M. Scheiman, Barbara J. McKenna in Journal of Gastrointestinal Surgery (2013)

previous disabled Page of 2